We are pleased that we are able to continuously expand our patent portfolio, adding new surgery specific instruments designed for use with the LTC electrosurgery generator. We believe the LTC technology, along with the underlying intellectual property, allows us the opportunity to make significant advances in the worldwide surgery markets. Having received the CE Mark approval on the electrosurgery generator and with commercial manufacturing of instruments and generator in-process, we hope to enter the European markets toward the end of this quarter or early next quarter.”
LTC’s Frank D’Amelio added, “These patent applications are related to our to-be-released new line of disposable bipolar sealing hemostats. Expanding our IP portfolio is a priority for the LTC management team in 2008. These four applications are a great start for our intellectual property pipeline. The concepts described and the claims within these applications were possible as a result of what we believe to be excellent and unique designs coming out of our design house, ViR Engineering.
I dont think so. the FDA were waiting on is for the LTC
electrosurgery generator. What they are talking about here are the disposal instruments. I think they have 5 different classes they are going to apply for FDA approval on.
That is my read on it. Am I miss reading the PR.
News 
Market Data 
Discover 
